ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Association Between Serum Galectin-3 Levels and Coronary Stenosis Severity in Patients With Coronary Artery Disease

Li, Mingxing; Guo, Kai; Huang, Xuansheng; Feng, Li; Yuan, Yong; Li, Jiewen; Lao, Yi; Guo, Zhigang*南方医科大学
Frontiers in Cardiovascular Medicine2022-2-7DOI: 10.3389/fcvm.2022.818162
9被引6阅读
引用收藏
分享

摘要

BackgroundThe relationship between galectin-3 (Gal-3) and coronary artery disease (CAD) has not been fully elucidated. AimThis study aimed to determine the relationship between the presence and severity of CAD and serum Gal-3 levels. Patients and MethodsThree-hundred thirty-one consecutive CAD patients were enrolled as the study group. An additional 62 patients without CAD were enrolled as the control group. Serum Gal-3 levels were separately compared between the non-CAD and CAD groups, among the stable CAD and Acute coronary syndrome (ACS) groups, and between CAD patients with low and high SYNTAX scores (SSs). The 1-year cumulative rate of major adverse cardiac events (MACEs) was also compared among ACS patients by Gal-3 levels. ResultsSerum Gal-3 was significantly higher in the CAD group than in the non-CAD group 3.89 (0.16-63.67) vs. 2.07 (0.23-9.38) ng/ml, P < 0.001. Furthermore, serum Gal-3 was significantly higher in the non-ST-segment elevation ACS (NSTE-ACS) group than that in the stable CAD group, 4.72 (1.0-16.14) vs. 2.23 (0.65-23.8) ng/ml, P = 0.04 and higher in the ST-segment elevation myocardial infarction (STEMI) group than that in the stable CAD group 7.87 (0.59-63.67) vs. 2.23 (0.65-23.8) ng/ml, P < 0.001. Serum Gal-3 level was an independent predictor of ACS compared with stable CAD group (OR = 1.131, 95% CI: 1.051-1.217, P = 0.001) as well as high SS (OR = 1.030, 95% CI: 1.021-1.047, P = 0.038) after adjust other confounding risk factors. Acute coronary syndrome patients with Gal-3 levels above the median (gal-3 = 4.78 ng/ml) showed a higher cumulative MACE rate than those with Gal-3 levels below the median. After adjusting other confounding risk factors, Gal-3 remained an independent risk factor for the cumulative rate of MACEs in ACS patients (6% higher rate of MACEs incidence per 1 ng/ml increment of Gal-3). ConclusionGalectin-3 correlated with the presence of CAD as well as coronary stability and complexity. Galectin-3 may be valuable in predicting mid-term prognosis in ACS patients.

学科与关键词

关键词
coronary artery diseasegalectin-3syntax scoreprognosisacute coronary syndrome
相关
加载中…
  • Circulating galectin-3 levels are inversely associated with subclinical cardiovascular disease in obese adults
    Zhang, Jinhua; Teng, Fei; Yuan, Youwen; Li, Kangli; Zhang, Peizhen; Wei, Xueyun; Liu, Deying; Zhang, Huijie*HEART AND VESSELS, 2023, 38(5): 671-679.
  • Prognostic Value of Serum Galectin-3 in Chronic Heart Failure: A Meta-Analysis
    Cheng, Zhendong; Cai, Kefeng; Xu, Chaoxian; Zhan, Qiong; Xu, Xingbo; Xu, Dingli*; Zeng, Qingchun*Frontiers in Cardiovascular Medicine, 2022, 9: 783707.被引 5
  • Identification of predictors for the comprehensive clinical risk and severity of coronary lesions of acute coronary syndrome
    Li, Lihui; Sun, Guangfeng; Yu, Jiangbo; Shan, Gaojun; Su, Lide; Dong, Guo*Frontiers in Cardiovascular Medicine, 2023, 10: 1046895.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cardiovascular Medicine
发表日期
2022-02-07
卷期
第 9 卷
页码
818162
DOI
10.3389/fcvm.2022.818162
期刊等级
3区
成果收录
SCIE

作者

  • L

    Li, Mingxing (第一作者)

    southern med univ · zhongshan peoples hosp

  • G

    Guo, Kai

    zhongshan peoples hosp

查看全部 8 位作者收起作者
  • H

    Huang, Xuansheng

    zhongshan peoples hosp

  • F

    Feng, Li

    zhongshan peoples hosp

  • Y

    Yuan, Yong

    zhongshan peoples hosp

  • L

    Li, Jiewen

    zhongshan peoples hosp

  • L

    Lao, Yi

    zhongshan peoples hosp

  • G

    Guo, Zhigang (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417